UY31673A1 - "derivados heterocíclicos de urea y métodos de uso de los mismos-211" - Google Patents
"derivados heterocíclicos de urea y métodos de uso de los mismos-211"Info
- Publication number
- UY31673A1 UY31673A1 UY031673A UY31673A UY31673A1 UY 31673 A1 UY31673 A1 UY 31673A1 UY 031673 A UY031673 A UY 031673A UY 31673 A UY31673 A UY 31673A UY 31673 A1 UY31673 A1 UY 31673A1
- Authority
- UY
- Uruguay
- Prior art keywords
- methods
- same
- heterocyclic derivatives
- urea
- urea heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Abstract
describe procesos para su preparación, composiciones farmacéuticas que los contienen, su uso como medicamentos y su uso en el tratamiento de infecciones bacterianas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3162108P | 2008-02-26 | 2008-02-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY31673A1 true UY31673A1 (es) | 2009-09-30 |
Family
ID=40474753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY031673A UY31673A1 (es) | 2008-02-26 | 2009-02-25 | "derivados heterocíclicos de urea y métodos de uso de los mismos-211" |
Country Status (23)
Country | Link |
---|---|
US (1) | US20120101100A1 (es) |
EP (1) | EP2262801A1 (es) |
JP (1) | JP2011513216A (es) |
KR (1) | KR20100117681A (es) |
CN (1) | CN102015699A (es) |
AR (1) | AR070493A1 (es) |
AU (1) | AU2009219883A1 (es) |
BR (1) | BRPI0907562A2 (es) |
CA (1) | CA2716365A1 (es) |
CL (1) | CL2009000426A1 (es) |
CO (1) | CO6290656A2 (es) |
CR (1) | CR11641A (es) |
DO (1) | DOP2010000259A (es) |
EA (1) | EA201001368A1 (es) |
EC (1) | ECSP10010419A (es) |
IL (1) | IL207731A0 (es) |
MX (1) | MX2010009163A (es) |
PE (1) | PE20091573A1 (es) |
SA (1) | SA109300138B1 (es) |
TW (1) | TW200940537A (es) |
UY (1) | UY31673A1 (es) |
WO (1) | WO2009106885A1 (es) |
ZA (1) | ZA201005997B (es) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2250160B1 (en) | 2008-01-25 | 2015-11-11 | Millennium Pharmaceuticals, Inc. | Thiophenes and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors |
US8865732B2 (en) | 2008-03-21 | 2014-10-21 | Novartis Ag | Heterocyclic compounds and uses thereof |
AU2012203026B2 (en) * | 2008-03-21 | 2014-06-12 | Novartis Ag | Novel heterocyclic compounds and uses thereof |
UY31864A (es) * | 2008-06-04 | 2010-01-29 | Astrazeneca Ab | Derivados de urea hetericíclica y métodos de uso de los mismos-332 |
WO2010052448A2 (en) * | 2008-11-05 | 2010-05-14 | Ucb Pharma S.A. | Fused pyrazine derivatives as kinase inhibitors |
RU2011123647A (ru) | 2008-11-10 | 2012-12-20 | Вертекс Фармасьютикалз Инкорпорейтед | Соединения, полезные в качестве ингибиторов atr киназы |
CN106496210B (zh) | 2008-12-19 | 2020-06-09 | 沃泰克斯药物股份有限公司 | 用作atr激酶抑制剂的化合物 |
CA2750935A1 (en) | 2009-01-30 | 2010-08-12 | Millennium Pharmaceuticals, Inc. | Heteroaryls and their use as pi3k inhibitors |
US9090601B2 (en) * | 2009-01-30 | 2015-07-28 | Millennium Pharmaceuticals, Inc. | Thiazole derivatives |
US8796314B2 (en) | 2009-01-30 | 2014-08-05 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
TW201102065A (en) | 2009-05-29 | 2011-01-16 | Astrazeneca Ab | Heterocyclic urea derivatives and methods of use thereof |
FR2953519B1 (fr) * | 2009-12-08 | 2012-02-10 | Commissariat Energie Atomique | Nouveaux composes chimiques aptes a complexer au moins un element metallique et complexe de coordination a base de ces composes |
US20130096119A1 (en) | 2010-03-31 | 2013-04-18 | Daniel Bur | Isoquinolin-3-Ylurea Derivatives |
AR081626A1 (es) | 2010-04-23 | 2012-10-10 | Cytokinetics Inc | Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos |
AR081331A1 (es) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
US9133123B2 (en) | 2010-04-23 | 2015-09-15 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
AU2011253025A1 (en) | 2010-05-12 | 2012-11-29 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
EP2568984A1 (en) | 2010-05-12 | 2013-03-20 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
WO2011143425A2 (en) | 2010-05-12 | 2011-11-17 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
WO2011143422A1 (en) * | 2010-05-12 | 2011-11-17 | Vertex Pharmaceuticals Incorporated | 2 -aminopyridine derivatives useful as inhibitors of atr kinase |
EP2569286B1 (en) | 2010-05-12 | 2014-08-20 | Vertex Pharmaceuticals Inc. | Compounds useful as inhibitors of atr kinase |
WO2011143419A1 (en) | 2010-05-12 | 2011-11-17 | Vertex Pharmaceuticals Incorporated | Pyrazines useful as inhibitors of atr kinase |
US8623869B2 (en) | 2010-06-23 | 2014-01-07 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
JP2013536193A (ja) | 2010-08-11 | 2013-09-19 | ミレニアム ファーマシューティカルズ, インコーポレイテッド | ヘテロアリール類およびその使用 |
WO2012021615A1 (en) | 2010-08-11 | 2012-02-16 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
WO2012021611A1 (en) | 2010-08-11 | 2012-02-16 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
US9056832B2 (en) * | 2010-09-17 | 2015-06-16 | Purdue Pharma L.P. | Pyridine compounds and the users thereof |
WO2012051410A2 (en) | 2010-10-13 | 2012-04-19 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
AR088729A1 (es) | 2011-03-29 | 2014-07-02 | Actelion Pharmaceuticals Ltd | Derivados de 3-ureidoisoquinolin-8-ilo y una composicion farmaceutica |
KR20140027974A (ko) | 2011-04-05 | 2014-03-07 | 버텍스 파마슈티칼스 인코포레이티드 | Tra 키나제의 억제제로서 유용한 아미노피라진 화합물 |
US8822469B2 (en) | 2011-06-22 | 2014-09-02 | Vertex Pharmaceuticals Incorporated | Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinase |
US9096602B2 (en) | 2011-06-22 | 2015-08-04 | Vertex Pharmaceuticals Incorporated | Substituted pyrrolo[2,3-B]pyrazines as ATR kinase inhibitors |
WO2012178125A1 (en) | 2011-06-22 | 2012-12-27 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
RU2014111321A (ru) * | 2011-09-12 | 2015-10-20 | Ф. Хоффманн-Ля Рош Аг | Гидразиды 3-пиридинкарбоновых кислот в качестве агентов, повышающих содержание холестерина липопротеинов высокой плотности |
MX2014003796A (es) | 2011-09-30 | 2015-01-16 | Vertex Pharma | Compuestos utiles como inhibidores de la cinasa ataxia telangiectasia mutada y rad3 relacionados (atr). |
EP2751088B1 (en) | 2011-09-30 | 2016-04-13 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
RU2677292C2 (ru) | 2011-09-30 | 2019-01-16 | Вертекс Фармасьютикалз Инкорпорейтед | Способы получения соединений, которые можно использовать в качестве ингибиторов киназы atr |
CA2850491C (en) | 2011-09-30 | 2020-10-27 | Vertex Pharmaceuticals Incorporated | Treating pancreatic cancer and non-small cell lung cancer with atr inhibiors |
US8853217B2 (en) | 2011-09-30 | 2014-10-07 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
KR20140088194A (ko) * | 2011-11-04 | 2014-07-09 | 에프. 호프만-라 로슈 아게 | 아릴-퀴놀린 유도체 |
EP2776429A1 (en) | 2011-11-09 | 2014-09-17 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
WO2013071093A1 (en) | 2011-11-09 | 2013-05-16 | Vertex Pharmaceuticals Incorporated | Pyrazine compounds useful as inhibitors of atr kinase |
WO2013071088A1 (en) | 2011-11-09 | 2013-05-16 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
US8841449B2 (en) | 2011-11-09 | 2014-09-23 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
EP2776422A1 (en) | 2011-11-09 | 2014-09-17 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
JP5957537B2 (ja) * | 2011-12-21 | 2016-07-27 | ビオタ ヨーロッパ リミテッドBiota Europe Ltd | 複素環式ウレア化合物 |
WO2013152298A1 (en) | 2012-04-05 | 2013-10-10 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase and combination therapies thereof |
JP5977349B2 (ja) * | 2012-06-15 | 2016-08-24 | 田辺三菱製薬株式会社 | 芳香族複素環化合物 |
DK2904406T3 (en) | 2012-10-04 | 2018-06-18 | Vertex Pharma | METHOD OF DETERMINING THE ATR INHIBITION, INCREASED DNA DAMAGE |
WO2014062604A1 (en) | 2012-10-16 | 2014-04-24 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
NZ731337A (en) | 2012-12-07 | 2019-02-22 | Vertex Pharma | Compounds useful as inhibitors of atr kinase |
US9242969B2 (en) | 2013-03-14 | 2016-01-26 | Novartis Ag | Biaryl amide compounds as kinase inhibitors |
JP2016512815A (ja) | 2013-03-15 | 2016-05-09 | バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated | Atrキナーゼの阻害剤として有用な縮合ピラゾロピリミジン誘導体 |
HUE039014T2 (hu) | 2013-09-06 | 2018-12-28 | Aurigene Discovery Tech Ltd | 1,3,4-Oxadiazol és 1,3,4-tiadiazol származékok, mint immunomodulátorok |
PL3077397T3 (pl) | 2013-12-06 | 2020-04-30 | Vertex Pharmaceuticals Inc. | Związek 2-amino-6-fluoro-n-[5-fluoro-pirydyn-3-ylo]pyrazolo [1,5-a]pirymidino-3-karboksamidu przydatny jako inhibitor kinazy atr, jego wytwarzanie, różne postacie stałe i ich radioznakowane pochodne |
SI3152212T1 (sl) | 2014-06-05 | 2020-06-30 | Vertex Pharmaceuticals Inc. | Radioaktivno označeni derivati 2-amino-6-fluoro-N-(5-fluoro-piridin-3-IL)-pirazolo (1,5-A)pirimidin-3- karboksamidne spojine, koristni kot inhibitor kinaze ATR, priprava navedene spojine in njene različne trdne oblike |
RS59054B1 (sr) | 2014-06-17 | 2019-08-30 | Vertex Pharma | Postupak za lečenje raka korišćenjem kombinacije chk1 i atr inhibitora |
UY36294A (es) | 2014-09-12 | 2016-04-29 | Novartis Ag | Compuestos y composiciones como inhibidores de quinasa |
CA2979163A1 (en) * | 2015-03-10 | 2016-09-15 | Aurigene Discovery Technologies Limited | 3-substituted 1,3,4-oxadiazole and thiadiazole compounds as immunomodulators |
AU2016331955B2 (en) | 2015-09-30 | 2022-07-21 | Vertex Pharmaceuticals Incorporated | Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors |
CN106866571B (zh) * | 2017-01-20 | 2018-06-29 | 中国药科大学 | 杂环脲类化合物及其药物组合物和应用 |
EP3604281A4 (en) | 2017-03-24 | 2020-08-19 | Taisho Pharmaceutical Co., Ltd. | 2 (1H) -CHINOLINONE DERIVATIVE |
CN111116559A (zh) * | 2018-11-01 | 2020-05-08 | 复旦大学 | 吡啶脲类化合物及其制备方法和制药用途 |
WO2022147210A1 (en) * | 2020-12-31 | 2022-07-07 | Evrys Bio, Llc | Anti-tumor compositions and methods |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0014022D0 (en) * | 2000-06-08 | 2000-08-02 | Novartis Ag | Organic compounds |
AR042956A1 (es) * | 2003-01-31 | 2005-07-13 | Vertex Pharma | Inhibidores de girasa y usos de los mismos |
US7569591B2 (en) * | 2003-01-31 | 2009-08-04 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
EP2102199B1 (en) * | 2006-12-04 | 2011-04-27 | AstraZeneca AB | Antibacterial polycyclic urea compounds |
-
2009
- 2009-02-24 TW TW098105845A patent/TW200940537A/zh unknown
- 2009-02-25 JP JP2010547261A patent/JP2011513216A/ja active Pending
- 2009-02-25 CL CL2009000426A patent/CL2009000426A1/es unknown
- 2009-02-25 EA EA201001368A patent/EA201001368A1/ru unknown
- 2009-02-25 BR BRPI0907562A patent/BRPI0907562A2/pt not_active IP Right Cessation
- 2009-02-25 SA SA109300138A patent/SA109300138B1/ar unknown
- 2009-02-25 MX MX2010009163A patent/MX2010009163A/es unknown
- 2009-02-25 CA CA2716365A patent/CA2716365A1/en not_active Abandoned
- 2009-02-25 US US12/392,730 patent/US20120101100A1/en not_active Abandoned
- 2009-02-25 WO PCT/GB2009/050187 patent/WO2009106885A1/en active Application Filing
- 2009-02-25 CN CN2009801157676A patent/CN102015699A/zh active Pending
- 2009-02-25 KR KR1020107021270A patent/KR20100117681A/ko not_active Application Discontinuation
- 2009-02-25 UY UY031673A patent/UY31673A1/es not_active Application Discontinuation
- 2009-02-25 AU AU2009219883A patent/AU2009219883A1/en not_active Abandoned
- 2009-02-25 EP EP09715006A patent/EP2262801A1/en not_active Withdrawn
- 2009-02-26 AR ARP090100667A patent/AR070493A1/es not_active Application Discontinuation
- 2009-02-26 PE PE2009000289A patent/PE20091573A1/es not_active Application Discontinuation
-
2010
- 2010-08-19 IL IL207731A patent/IL207731A0/en unknown
- 2010-08-23 ZA ZA2010/05997A patent/ZA201005997B/en unknown
- 2010-08-24 DO DO2010000259A patent/DOP2010000259A/es unknown
- 2010-08-24 CO CO10104182A patent/CO6290656A2/es not_active Application Discontinuation
- 2010-08-24 CR CR11641A patent/CR11641A/es not_active Application Discontinuation
- 2010-08-24 EC EC2010010419A patent/ECSP10010419A/es unknown
Also Published As
Publication number | Publication date |
---|---|
US20120101100A1 (en) | 2012-04-26 |
CN102015699A (zh) | 2011-04-13 |
PE20091573A1 (es) | 2009-11-12 |
ECSP10010419A (es) | 2010-09-30 |
JP2011513216A (ja) | 2011-04-28 |
CL2009000426A1 (es) | 2011-02-11 |
CR11641A (es) | 2010-10-05 |
WO2009106885A1 (en) | 2009-09-03 |
CA2716365A1 (en) | 2009-09-03 |
SA109300138B1 (ar) | 2012-11-03 |
EP2262801A1 (en) | 2010-12-22 |
DOP2010000259A (es) | 2010-09-15 |
EA201001368A1 (ru) | 2011-04-29 |
TW200940537A (en) | 2009-10-01 |
IL207731A0 (en) | 2010-12-30 |
AU2009219883A1 (en) | 2009-09-03 |
AR070493A1 (es) | 2010-04-07 |
ZA201005997B (en) | 2013-01-30 |
KR20100117681A (ko) | 2010-11-03 |
BRPI0907562A2 (pt) | 2017-05-23 |
CO6290656A2 (es) | 2011-06-20 |
MX2010009163A (es) | 2010-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY31673A1 (es) | "derivados heterocíclicos de urea y métodos de uso de los mismos-211" | |
ECSP099451A (es) | Compuestos de urea policíclicos antibacterianos | |
UY32158A (es) | Derivados heterociclicos y metodos de uso de los mismos | |
UY32315A (es) | Compuestos de piperidina y usos de los mismo-596 | |
CL2011003350A1 (es) | Compuestos derivados de heterociclo nitrogenados, moduladores pkm2; composicion farmaceutica que los comprende; y su uso en el tratamiento del cancer. | |
UY31860A (es) | Piridinas de tiazolo como inhibidoras de la adn girasa | |
CL2011000729A1 (es) | Compuestos derivados de metanopirazolo[3,4-e][1,3]diazepin; procedimiento de preparacion; composicion farmaceutica que los comprende; y su uso en el tratamiento de infecciones bacterianas. | |
CL2011000846A1 (es) | Compuestos heterociclicos sustituidos; composicion farmaceutica; y su uso para el tratamiento de la hepatitis c. | |
EA033311B1 (ru) | Производные бензоксаборола в качестве антибактериальных средств | |
UY31864A (es) | Derivados de urea hetericíclica y métodos de uso de los mismos-332 | |
BRPI0810064B8 (pt) | compostos contendo nitrogênio tricíclico como agentes antibacterianos, composições farmacêuticas que compreendem os ditos compostos e uso dos mesmos para o tratamento de infecções bacterianas em mamíferos | |
CO6390082A2 (es) | Compuestos organicos | |
UY30544A1 (es) | Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones | |
UY29732A1 (es) | Derivados de benzotiazolonas, procesos de preparación, composiciones y combinaciones que los contienen y aplicaciones | |
ECSP10010659A (es) | Derivados heterocíclicos de la urea y sus métodos de empleo | |
UY31141A1 (es) | Compuestos de piperidina y sus usos | |
PA8720801A1 (es) | Nuevas combinaciones terapeuticas para el tratamiento de la depresion | |
CL2008001123A1 (es) | Compuestos derivados de acido lipoico; formulacion farmaceutica que lo comprende; y uso en el tratamiento del cancer. | |
UY32856A (es) | Derivados heterocíclicos de urea y métodos de uso de los mismos | |
UY32674A (es) | Derivados heterociclicos de la urea y sus metodos de empleo | |
UY32694A (es) | Derivados heterocíclicos de urea y métodos de uso de los mismos | |
CL2012001757A1 (es) | Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica; y su uso en el tratamiento de infecciones micoticas. | |
UY32316A (es) | Derivados de piperidina utiles en el tratamiento de infecciones bacterianas | |
AR072426A1 (es) | Uso de nifurtimox para el tratamiento de enfermedades causadas por tricomonadida | |
UY31805A (es) | Agonistas m1, composiciones farmacéuticas de los mismos, procesos para su preparacion y sus usos para el tratamiento del dolor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20180831 |